期刊文献+

小鼠H pylori长期感染模型研究 被引量:1

Establishment of mouse models with long-term infection of H pylori
下载PDF
导出
摘要 目的:用H pylori SSl(Sydney strainl)感染C57BL/6小鼠及Balb/c小鼠,建立稳定的H pylori感染的小鼠实验动物模型. 方法:通过灌胃的方式用H pylori SS1菌株感染二级C57BL/6小鼠和Balb/c小鼠,灌胃后4、12及24 wk分三次处死动物,用胃黏膜匀浆液进行细菌培养试验、尿素酶试验、胃病理组织学检查以及血清学抗体检测试验. 结果:灌胃4wk后,处死的7只Balb/c小鼠经胃组织细菌培养发现有6只显示阳性结果;处死的7只C57BL/6小鼠中有5只显示阳性结果.12和24wk后的实验组7只Balb/c 小鼠胃组织细菌培养均为阳性,而7只C57BL/6小鼠中有6只显示阳性结果.在不同阶段尿素酶检测的阳性结果与细菌培养法结果一致.实验组动物胃窦部及胃体部均出现了轻度至中度慢性活动性胃炎变化;血清学IgG检查表明,各实验组的实验动物产生了抗H pylori血清抗体;而对照组动物的胃黏膜匀浆液经各项检测均为阴性. 结论:成功地建立了H AIM: To develop a mouse model with long-term infection of H pylori. METHODS: Each mouse was inoculated with H pylori Sydney strain 1 (SS1). Noninfected control mice and infected mice were killed at 4, 12 and 24 wk after H pylori infection. A piece of gastric mucosa obtained from the posterior wall of the antrum of each mouse was used for culture of H pylori, rapid urease testing and histopatho-logical detection. Serum was obtained to measure the IgG antibody level to H pylori. RESULTS: After 4 wk of infection, the H pyloriwas cultured from 6 of 7 infected Babl/c mice and 5 of 7 the H pylori-infected C57BL/6 mice. After 12 and 24 wk of infection, all of 7 infected Babl/c and 6 of 7 the H pylori infected C57BL/6 mice showed the positive results. At the different wk, the rapid urease test results were consistent with the H pylori culture test. At 12 wk after inoculation, chronic inflammation was observed in the pyloric mucosa by histopathological examination. At 24 wk after inoculation, lymphoid follicles were especially conspicuous in the submucosa, and they were also found in the deep portion of the mucosa. CONCLUSION: H pylori SSI can colonize easily in the glandular stomach mucosa of mouse, and the histopathological changes are similar to those of humans with H pylori infection.
出处 《世界华人消化杂志》 CAS 2004年第3期626-629,共4页 World Chinese Journal of Digestology
基金 国家"十五"863高技术研究发展计划基金资助项目 No.2001AA215161~~
  • 相关文献

参考文献35

  • 1Shimoyama T, Fukuda Y, Sakagami T. The present status and problems of Helicobacter pylori eradication therapy with a special reference to gastric cancer. Nippon Rinsho 2003;61:137-145.
  • 2Nishibayashi H, Kanayama S, Kiyohara T, Yamamoto K,Miyazaki Y, Yasunaga Y, Shinomura Y, Takeshita T, Takeuchi T, Morimoto K, Matsuzawa Y. Helicobacter pylori-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma. J Gastroenterol Hepatol 2003;18:1384-1391.
  • 3Suleymanov Z. Expression of class I and Ⅱ MHC receptors in Helicobacter pylori-positive patients with active gastritis and duodenal ulcer. Turk J Gastroenterol 2003;14:168-172.
  • 4Wong JE, Ito Y, Correa P, Peeters KC, van de Velde CJ, Sasako M, Macdonald J. Therapeutic strategies in gastric cancer. Clin Oncol 2003;21(23 Suppl):267s-269s.
  • 5Yanai A, Hirata Y, Mitsuno Y, Maeda S, Shibata W, Akanuma M, Yoshida H, Kawabe T, Omata M. Helicobacter pylori induces antiapoptosis through buclear factor-kappaB activation. J Infect Dis 2003;188:1741-1751.
  • 6Loughlin MF. Novel therapeutic targets in Helicobacter pylori.Expert Opin Ther Targets 2003;7:725-735.
  • 7Perri F, Qasim A, Marras L, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter 2003;8(Suppl 1):53-60.
  • 8Lamarque D, M Peek R Jr. Pathogenesis of Helicobacter pylori infection. Helicobacter 2003;8(Suppl 1):21-30.
  • 9Nardone G, Morgner A. Helicobacter pylori and gastric malignancies. Helicobacter 2003;8(Suppl 1):44-52.
  • 10Robertson MS, Clancy RL, Cade JF. Helicobacter pylori in intensive care: why we should be interested. Intensive Care Med 2003;29:1881-1888.

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部